Haosheng Shen

600 total citations · 1 hit paper
8 papers, 484 citations indexed

About

Haosheng Shen is a scholar working on Molecular Biology, Infectious Diseases and Biotechnology. According to data from OpenAlex, Haosheng Shen has authored 8 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Biotechnology. Recurrent topics in Haosheng Shen's work include Cancer Research and Treatments (2 papers), Probiotics and Fermented Foods (2 papers) and Gut microbiota and health (2 papers). Haosheng Shen is often cited by papers focused on Cancer Research and Treatments (2 papers), Probiotics and Fermented Foods (2 papers) and Gut microbiota and health (2 papers). Haosheng Shen collaborates with scholars based in China, Singapore and United States. Haosheng Shen's co-authors include Zhimou Yang, Jie Zhan, Yanbin Cai, Jie Gao, Chunhua Ren, Mingliang Lin, Yang Shi, Jianfeng Liu, Matthew Wook Chang and Yung Seng Lee and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Haosheng Shen

8 papers receiving 479 citations

Hit Papers

Engineered commensals for targeted nose-to-brain drug del... 2025 2026 2025 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haosheng Shen China 8 273 205 131 63 54 8 484
Shoko Itakura Japan 13 259 0.9× 131 0.6× 115 0.9× 42 0.7× 18 0.3× 49 534
Chien-Han Kao Taiwan 15 296 1.1× 98 0.5× 98 0.7× 55 0.9× 28 0.5× 28 496
Bindu Thapa Canada 14 364 1.3× 177 0.9× 139 1.1× 52 0.8× 17 0.3× 26 611
Taehun Hong Japan 11 274 1.0× 113 0.6× 86 0.7× 27 0.4× 16 0.3× 22 442
Maryam A. Shetab Boushehri Germany 13 238 0.9× 142 0.7× 125 1.0× 26 0.4× 17 0.3× 24 583
Kıvılcım Öztürk Türkiye 12 190 0.7× 217 1.1× 136 1.0× 43 0.7× 17 0.3× 14 498
Jérôme Bejaud France 17 352 1.3× 269 1.3× 157 1.2× 88 1.4× 12 0.2× 28 698
Maohua Chen China 9 171 0.6× 75 0.4× 196 1.5× 49 0.8× 70 1.3× 18 440
Sunhui Chen China 11 329 1.2× 210 1.0× 169 1.3× 29 0.5× 10 0.2× 19 591
Rohan Lalani India 16 263 1.0× 221 1.1× 108 0.8× 45 0.7× 13 0.2× 21 605

Countries citing papers authored by Haosheng Shen

Since Specialization
Citations

This map shows the geographic impact of Haosheng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haosheng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haosheng Shen more than expected).

Fields of papers citing papers by Haosheng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haosheng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haosheng Shen. The network helps show where Haosheng Shen may publish in the future.

Co-authorship network of co-authors of Haosheng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Haosheng Shen. A scholar is included among the top collaborators of Haosheng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haosheng Shen. Haosheng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Shen, Haosheng, Nikhil Aggarwal, Yuanzhi He, et al.. (2025). Engineered commensals for targeted nose-to-brain drug delivery. Cell. 188(6). 1545–1562.e16. 37 indexed citations breakdown →
2.
Shen, Haosheng, Changyu Zhang, Yuanmei Liang, et al.. (2024). Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy. Nature Communications. 15(1). 4343–4343. 32 indexed citations
3.
Ling, Hua, Ruirui Liu, Qi Hui Sam, et al.. (2023). Engineering of a probiotic yeast for the production and secretion of medium-chain fatty acids antagonistic to an opportunistic pathogen Candida albicans. Frontiers in Bioengineering and Biotechnology. 11. 1090501–1090501. 11 indexed citations
4.
Shen, Haosheng, Nikhil Aggarwal, K.S. Wun, et al.. (2022). Engineered microbial systems for advanced drug delivery. Advanced Drug Delivery Reviews. 187. 114364–114364. 45 indexed citations
5.
Shen, Haosheng, In Young Hwang, Hua Ling, et al.. (2018). Targeted Approaches for In Situ Gut Microbiome Manipulation. Genes. 9(7). 351–351. 39 indexed citations
6.
Feng, Jun, Yanyan Gu, Fenghong Liu, et al.. (2017). Enhancing poly-γ-glutamic acid production in Bacillus amyloliquefaciens by introducing the glutamate synthesis features from Corynebacterium glutamicum. Microbial Cell Factories. 16(1). 88–88. 22 indexed citations
7.
Cai, Yanbin, Haosheng Shen, Jie Zhan, et al.. (2017). Supramolecular “Trojan Horse” for Nuclear Delivery of Dual Anticancer Drugs. Journal of the American Chemical Society. 139(8). 2876–2879. 269 indexed citations
8.
Cai, Yanbin, Jie Zhan, Haosheng Shen, et al.. (2015). Optimized Ratiometric Fluorescent Probes by Peptide Self-Assembly. Analytical Chemistry. 88(1). 740–745. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026